A*STAR Genome Institute of Singapore (A*STAR GIS)

In recognition of their research excellence, leadership and impact both locally and globally, ten leading A*STAR researchers have been awarded the A*STAR Distinguished Fellowship and Fellowships.

From biomedical research to generative AI models, scientific progress depends on strong ethical standards that maintain integrity, transparency and accountability.

A groundbreaking multinational atlas of the body’s frontline defenders reveals hidden variations that could enhance precision health efforts worldwide.

A new ‘liquid lipid’ approach that penetrates the nose’s mucus barrier could lead to needle-free, nasal spray-based mRNA vaccines.

Targeting a key gene can help prevent the body’s immune fighters from wearing out when attacking tumour cells, offering a new treatment strategy against cancer.

A*STAR researchers discover how subtle changes to a packaging component of mRNA vaccines can boost their efficacy and safety.

Integrating molecular insights from several omics profiling approaches, A*STAR research initiatives are deepening our understanding of human physiology and unearthing new diagnostic and therapeutic opportunities.

From innovative medical devices to advanced manufacturing partnerships, the work of A*STAR recipients of the 2024 President’s Science and Technology Awards exemplify the importance of translating research into clinical and commercial outcomes.

Scientists identify a new, distinct group of the deadly yeast Candida auris, and urge the expansion of global surveillance efforts.

A large-scale gut microbiome study in elderly Singaporeans reveals new insights into the role of our resident microbes in healthy ageing.

A detailed map of genetic variations in a key drug-processing enzyme reveals new precision medicine insights for patients of Asian ancestry.

Fascinated by genome editing’s potential, A*STAR scholar Chen Gang Goh is advancing research on DNA repair pathways and their implications for gene therapy in cancer.